{"id":200403,"date":"2025-06-08T17:33:09","date_gmt":"2025-06-08T17:33:09","guid":{"rendered":"https:\/\/yogaesoteric.net\/?p=200403"},"modified":"2025-06-08T17:33:09","modified_gmt":"2025-06-08T17:33:09","slug":"fda-the-regulatory-facade-approved-hundreds-of-drugs-with-no-proof-they-worked-turning-patients-into-unwitting-guinea-pigs","status":"publish","type":"post","link":"https:\/\/yogaesoteric.net\/en\/fda-the-regulatory-facade-approved-hundreds-of-drugs-with-no-proof-they-worked-turning-patients-into-unwitting-guinea-pigs\/","title":{"rendered":"FDA \u2013 the regulatory facade \u2013 approved hundreds of drugs with no proof they worked, turning patients into unwitting guinea pigs"},"content":{"rendered":"

The U.S. Food and Drug Administration (FDA), once regarded as the gold standard for drug safety, has devolved into little more than a rubber stamp for Big Pharma \u2013 approving hundreds of medications with shockingly little evidence that they actually help patients<\/a>. A bombshell two-year investigation by The Lever<\/em><\/a> reveals that the agency has abandoned its own scientific standards, fast-tracking dangerous and ineffective drugs while leaving patients to suffer the consequences.<\/p>\n

\"\"<\/p>\n

The FDA\u2019s accelerated pathway: A license for corporate greed<\/strong><\/p>\n

The FDA\u2019s descent into regulatory negligence<\/a> traces back to the AIDS crisis of the 1980s. Desperate patients demanded faster access to experimental treatments, and Big Pharma seized the opportunity to push for looser standards. In 1992, the agency introduced the \u201caccelerated pathway<\/em>,\u201d allowing drug makers to submit preliminary data \u2013 often based on unreliable surrogate markers \u2013 instead of concrete clinical outcomes.<\/p>\n

One notorious example was AZT<\/em>, an AIDS drug approved solely because it increased T-cell counts \u2013 despite failing to improve survival rates and causing severe toxicity. GlaxoSmithKline (GSK) raked in $2 billion before the truth emerged.<\/p>\n

Congress cemented this reckless approach with the Prescription Drug User Fee Act<\/em> (PDUFA), effectively turning the FDA into a pay-to-play operation. Pharmaceutical lobbying skyrocketed, with campaign contributions doubling from 1.9 million in 1990 to 3.6 million in 1992 \u2013 just before the bill passed.<\/p>\n

Flimsy science, deadly consequences<\/strong><\/p>\n

The Lever<\/em>\u2019s investigation identified four basic criteria the FDA once required to prove a drug\u2019s effectiveness:<\/p>\n